Related Experiment Videos

DNA content--a prognostic factor in childhood medulloblastoma?

M Mandel¹, A Toren, O Nativ

¹Institute of Hematology, Cahim Sheba Medical Center, Tel-Aviv University, Israel.

Acta Oncologica (Stockholm, Sweden)

|January 1, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Significant clinical and radiologic response to targeted therapy in pediatric cervicomedullary low-grade gliomas harboring the BRAFV600E mutation.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2025

Optimization of ciliary body cyclophotocoagulation settings: a randomized and controlled pilot study.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2025

Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas.

AJNR. American journal of neuroradiology·2016

In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.

Current oncology (Toronto, Ont.)·2016

Hematopoietic stem cell donation: psychological perspectives of pediatric sibling donors and their parents.

Bone marrow transplantation·2015

SLC1A4 mutations cause a novel disorder of intellectual disability, progressive microcephaly, spasticity and thin corpus callosum.

Clinical genetics·2015

See all related articles